A recently published research paper “Variant of TYR and Autoimmunity Susceptibility Loci in Generalized Vitiligo” by among others Professor Richard Spritz, Professor Dorothy Bennett and Professor David Gawkrodger could have identified that vitiligo may give natural protection against deadly skin cancer.
Good progress is being made on the Genomewide Study. Stages 1 and 2 of the study, which included 5350 Caucasian (white) patients and their relatives, are now complete, but new participants are required to strengthen the findings.
Major Research funding for
vitiligo treatment research as part of £1.8 million grant
awarded over five years for four skin diseases by the National
Institute for Health Research.